Profile

Janet A. Englund, MD

Janet A. Englund, MD

Infectious Disease, Infectious Disease Research

On staff since November 2002

Academic Title: Professor

Research Center: Center for Clinical and Translational Research

"Ive always been interested in preventing disease. Finding ways to keep children healthy is what I love to do. I began focusing on vaccines because they are one of the best ways to stop children and adults from getting sick in the first place. By working to make vaccines safe and effective, I feel like I'm making a difference in the lives of many people around the world."

Janet A. Englund, MD: Professor of Pediatric Infectious Diseases. My research interests include the study of vaccine-preventable diseases and viral respiratory diseases in young children and immunocompromised hosts, including transplant recipients, as well as the evaluation of antiviral therapy for the prevention and treatment of viral diseases.

As a Clinical Associate at Fred Hutchinson Cancer Research Center, I am active in many transplant-related protocols in the prevention and treatment of disease in the immunocompromised host. As a member of the NIH-sponsored Seattle Vaccine Treatment and Evaluation Unit, I am involved in research with new vaccines and maternal immunization with Tdap and influenza vaccines. I am also involved in the evaluation of new respiratory virus vaccines including live-attenuated parainfluenza virus vaccines through collaboration with Johns Hopkins University and the NIH. My research group is active in studying influenza virus vaccines in diverse populations, including infants, school-age children in the schools, and pregnant women, as well as the development of antiviral resistance and novel methods of antiviral therapy.

Making A Difference

Overview

Board Certification(s)

Pediatrics
Pediatric Infectious Diseases

Medical/Professional School

University of Michigan Medical School, Ann Arbor

Residency

Pediatrics, Fairview University Medical Center, Minneapolis

Fellowship

Infectious Disease, University of Minnesota , Minneapolis
Infectious Disease, University of Minnesota , Minneapolis

Research Description

My research interests include the study of vaccine-preventable diseases and viral respiratory diseases in young children and immunocompromised hosts, including transplant recipients, as well as the evaluation of antiviral therapy for the prevention and treatment of viral diseases.

As a Clinical Associate of Fred Hutchinson Cancer Research Center, I am active in many transplant-related protocols in the prevention and treatment of disease in the immunocompromised host. As a member of the NIH-sponsored Seattle Vaccine Treatment and Evaluation Unit, I am involved in research with new vaccines and maternal immunization with Tdap and influenza vaccines.

My research group is active in studying influenza virus vaccines in diverse populations, including infants, school-age children in the schools, and pregnant women.

Research Focus Area

Immunocompromised Hosts, Virology, Infectious Disease

Awards and Honors

Award Name Award Description Awarded By Award Date
SEATTLE'S TOP DOCTOR - 2014 Seattle Metropolitan Magazine 2014
Seattle's Top Doc Seattle Met Magazine 2013

Publications

  • Waghmare A, Campbell AP, Xie H, Seo S, Kuypers J, Leisenring W, Jerome KR, Englund JA, Boeckh M
    Respiratory syncytial virus lower respiratory disease in hematopoietic cell transplant recipients: viral RNA detection in blood, antiviral treatment, and clinical outcomes.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America , 2013 Dec. : 57(12)1731-41
  • Englund JA, Karron RA, Cunningham CK, Larussa P, Melvin A, Yogev R, Handelsman E, Siberry GK, Thumar B, Schappell E, Bull CV, Chu HY, Schaap-Nutt A, Buchholz U, Collins PL, Schmidt AC, International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1096 Study Group
    Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children.
    Vaccine , 2013 Nov. 19 : 31(48)5706-12
  • Chu HY, Kuypers J, Renaud C, Wald A, Martin E, Fairchok M, Magaret A, Sarancino M, Englund JA
    Molecular epidemiology of respiratory syncytial virus transmission in childcare.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology , 2013 Aug. : 57(4)343-50
  • Renaud C, Xie H, Seo S, Kuypers J, Cent A, Corey L, Leisenring W, Boeckh M, Englund JA
    Mortality rates of human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic cell transplantation recipients.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation , 2013 Aug. : 19(8)1220-6
  • Seo S, Campbell AP, Xie H, Chien JW, Leisenring WM, Englund JA, Boeckh M
    Outcome of respiratory syncytial virus lower respiratory tract disease in hematopoietic cell transplant recipients receiving aerosolized ribavirin: significance of stem cell source and oxygen requirement.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation , 2013 Apr, : 19(4)589-96
  • Martin ET, Fairchok MP, Stednick ZJ, Kuypers J, Englund JA
    Epidemiology of multiple respiratory viruses in childcare attendees.
    The Journal of infectious diseases , 2013 Mar. 15 : 207(6)982-9
  • Kimberlin DW, Acosta EP, Prichard MN, Sánchez PJ, Ampofo K, Lang D, Ashouri N, Vanchiere JA, Abzug MJ, Abughali N, Caserta MT, Englund JA, Sood SK, Spigarelli MG, Bradley JS, Lew J, Michaels MG, Wan W, Cloud G, Jester P, Lakeman FD, Whitley RJ, National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group
    Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza.
    The Journal of infectious diseases , 2013 Mar. 1 : 207(5)709-20
  • Janet A. Englund, MD
    Human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic stem cell transplant recipients have high mortality rates.
    BBMT , 2013 : 191220-6
  • Campbell AP, Kuypers J, Englund JA, Guthrie KA, Corey L, Boeckh M
    Self-collection of foam nasal swabs for respiratory virus detection by PCR among immunocompetent subjects and hematopoietic cell transplant recipients.
    Journal of clinical microbiology , 2013 Jan. : 51(1)324-7
  • Seo S, Englund JA, Nguyen JT, Pukrittayakamee S, Lindegardh N, Tarning J, Tambyah PA, Renaud C, Went GT, de Jong MD, Boeckh MJ
    Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics.
    Antiviral therapy , 2013 : 18(3)377-86
  • Xu M, Qin X, Astion ML, Rutledge JC, Simpson J, Jerome KR, Englund JA, Zerr DM, Migita RT, Rich S, Childs JC, Cent A, Del Beccaro MA
    Implementation of filmarray respiratory viral panel in a core laboratory improves testing turnaround time and patient care.
    American journal of clinical pathology , 2013 Jan. : 139(1)118-23
  • Choi SM, Xie H, Campbell AP, Kuypers J, Leisenring W, Boudreault AA, Englund JA, Corey L, Boeckh M
    Influenza viral RNA detection in blood as a marker to predict disease severity in hematopoietic cell transplant recipients.
    The Journal of infectious diseases , 2012 Dec. 15 : 206(12)1872-7
  • Kuypers J, Campbell AP, Guthrie KA, Wright NL, Englund JA, Corey L, Boeckh M
    WU and KI polyomaviruses in respiratory samples from allogeneic hematopoietic cell transplant recipients.
    Emerging infectious diseases , 2012 Oct. : 18(10)1580-8
  • Burns JL, Emerson J, Kuypers J, Campbell AP, Gibson RL, McNamara S, Worrell K, Englund JA
    Respiratory viruses in children with cystic fibrosis: viral detection and clinical findings.
    Influenza and other respiratory viruses , 2012 May : 6(3)218-23
  • Martin ET, Kuypers J, Wald A, Englund JA
    Multiple versus single virus respiratory infections: viral load and clinical disease severity in hospitalized children.
    Influenza and other respiratory viruses , 2012 Jan. : 6(1)71-7
  • Renaud C, Englund JA
    Antiviral therapy of respiratory viruses in haematopoietic stem cell transplant recipients.
    Antiviral therapy , 2012 : 17(1 Pt B)175-91
  • Munoz F, Englund J
    Infant pertussis: is cocooning the answer?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America , 2011 Nov. : 53(9)893-6
  • Renaud C, Kuypers J, Englund JA
    Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology , 2011 Oct. : 52(2)70-8
  • Fairchok MP, Martin ET, Kuypers J, Englund JA
    A prospective study of parainfluenza virus type 4 infections in children attending daycare.
    The Pediatric infectious disease journal , 2011 Aug. : 30(8)714-6
  • Boudreault AA, Xie H, Leisenring W, Englund J, Corey L, Boeckh M
    Impact of corticosteroid treatment and antiviral therapy on clinical outcomes in hematopoietic cell transplant patients infected with influenza virus.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation , 2011 July : 17(7)979-86
  • Ortiz JR, Englund JA, Neuzil KM
    Influenza vaccine for pregnant women in resource-constrained countries: a review of the evidence to inform policy decisions.
    Vaccine , 2011 June 15 : 29(27)4439-52
  • Halasa N, Englund JA, Nachman S, Weinberg GA, Huber VC, Allison K, Dubovsky F, Yi T, McCullers JA, Flynn PM
    Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer.
    Vaccine , 2011 May 31 : 29(24)4110-5
  • Renaud C, Kuypers J, Ficken E, Cent A, Corey L, Englund JA
    Introduction of a novel parechovirus RT-PCR clinical test in a regional medical center.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology , 2011 May : 51(1)50-3
  • Kay M, Zerr DM, Englund JA, Cadwell BL, Kuypers J, Swenson P, Kwan-Gett TS, Bell SL, Duchin JS
    Shedding of pandemic (H1N1) 2009 virus among health care personnel, Seattle, Washington, USA.
    Emerging infectious diseases , 2011 Apr, : 17(4)639-44
  • Renaud C, Boudreault AA, Kuypers J, Lofy KH, Corey L, Boeckh MJ, Englund JA
    H275Y mutant pandemic (H1N1) 2009 virus in immunocompromised patients.
    Emerging infectious diseases , 2011 Apr, : 17(4)653-60; quiz 765
  • Taylor JA, Weber WJ, Martin ET, McCarty RL, Englund JA
    Development of a symptom score for clinical studies to identify children with a documented viral upper respiratory tract infection.
    Pediatric research , 2010 Sept. : 252-7
  • Fairchok MP, Martin ET, Chambers S, Kuypers J, Behrens M, Braun LE, Englund JA
    Epidemiology of viral respiratory tract infections in a prospective cohort of infants and toddlers attending daycare.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology , 2010 Sept. : 16-20
  • Singleton RJ, Bulkow LR, Miernyk K, DeByle C, Pruitt L, Hummel KB, Bruden D, Englund JA, Anderson LJ, Lucher L, Holman RC, Hennessy TW
    Viral respiratory infections in hospitalized and community control children in Alaska.
    Journal of medical virology , 2010 July : 82(7)1282-90
  • Singleton RJ, Bulkow LR, Miernyk K, DeByle C, Pruitt L, Hummel KB, Bruden D, Englund JA, Anderson LJ, Lucher L, Holman RC, Hennessy TW
    Viral respiratory infections in hospitalized and community control children in Alaska.
    Journal of medical virology , 2010 July : 1282-90
  • Walter EB, Rajagopal S, Zhu Y, Neuzil KM, Fairchok MP, Englund JA
    Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23 months of age: do children of all ages respond equally?
    Vaccine , 2010 June 17 : 28(27)4376-83
  • Walter EB, Rajagopal S, Zhu Y, Neuzil KM, Fairchok MP, Englund JA
    Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23 months of age: do children of all ages respond equally?
    Vaccine , 2010 June 17 : 4376-83
  • Martin ET, Fairchok MP, Kuypers J, Magaret A, Zerr DM, Wald A, Englund JA
    Frequent and prolonged shedding of bocavirus in young children attending daycare.
    The Journal of infectious diseases , 2010 June 1 : 1625-32
  • Campbell AP, Jacob ST, Kuypers J, Wald A, Englund JA, Corey L, Boeckh M
    Respiratory failure caused by 2009 novel influenza A/H1N1 in a hematopoietic stem-cell transplant recipient: Detection of extrapulmonary H1N1 RNA and use of intravenous peramivir.
    Annals of internal medicine , 2010 May 4 : 619-20
  • Milano F, Campbell AP, Guthrie KA, Kuypers J, Englund JA, Corey L, Boeckh M
    Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipients.
    Blood , 2010 Mar. 11 : 2088-94
  • Casper C, Englund J, Boeckh M
    How I treat influenza in patients with hematologic malignancies.
    Blood , 2010 Feb. 18 : 115(7)1331-42
  • Englund JA, Walter E, Black S, Blatter M, Nyberg J, Ruben FL, Decker MD, GRC28 Study Team
    Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study.
    The Pediatric infectious disease journal , 2010 Feb. : 29(2)105-10
  • Englund JA, Walter E, Black S, Blatter M, Nyberg J, Ruben FL, Decker MD
    Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study.
    The Pediatric infectious disease journal , 2010 Feb. : 105-10
  • Advisory Committee on Immunization Practices
    Recommended adult immunization schedule: United States, 2010.
    Annals of internal medicine , 2010 Jan. 5 : 152(1)36-9
  • Martin ET, Taylor J, Kuypers J, Magaret A, Wald A, Zerr D, Englund JA
    Detection of bocavirus in saliva of children with and without respiratory illness.
    Journal of clinical microbiology , 2009 Dec. : 47(12)4131-2
  • Martin ET, Taylor J, Kuypers J, Magaret A, Wald A, Zerr D, Englund JA
    Detection of bocavirus in saliva of children with and without respiratory illness.
    Journal of clinical microbiology , 2009 Dec. : 4131-2
  • Walter EB, Englund JA, Blatter M, Nyberg J, Ruben FL, Decker MD
    Trivalent inactivated influenza virus vaccine given to two-month-old children: an off-season pilot study.
    The Pediatric infectious disease journal , 2009 Dec. : 1099-104
  • Verghese PS, Finn LS, Englund JA, Sanders JE, Hingorani SR
    BK nephropathy in pediatric hematopoietic stem cell transplant recipients.
    Pediatric transplantation , 2009 Nov. : 913-8
  • Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, McGeer AJ, Neuzil KM, Pavia AT, Tapper ML, Uyeki TM, Zimmerman RK
    Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America , 2009 Apr, 15 : 1003-32
  • Stempel HE, Martin ET, Kuypers J, Englund JA, Zerr DM
    Multiple viral respiratory pathogens in children with bronchiolitis.
    Acta paediatrica (Oslo, Norway : 1992) , 2009 Jan. : 98(1)123-6
  • Stempel HE, Martin ET, Kuypers J, Englund JA, Zerr DM
    Multiple viral respiratory pathogens in children with bronchiolitis.
    Acta paediatrica (Oslo, Norway : 1992) , 2009 Jan. : 123-6
  • Martin ET, Kuypers J, Heugel J, Englund JA
    Clinical disease and viral load in children infected with respiratory syncytial virus or human metapneumovirus.
    Diagnostic microbiology and infectious disease , 2008 Dec. : 62(4)382-8
  • Martin ET, Kuypers J, Heugel J, Englund JA
    Clinical disease and viral load in children infected with respiratory syncytial virus or human metapneumovirus.
    Diagnostic microbiology and infectious disease , 2008 Dec. : 382-8
  • Qin X, Zerr DM, Weissman SJ, Englund JA, Denno DM, Klein EJ, Tarr PI, Kwong J, Stapp JR, Tulloch LG, Galanakis E
    Prevalence and mechanisms of broad-spectrum beta-lactam resistance in Enterobacteriaceae: a children's hospital experience.
    Antimicrobial agents and chemotherapy , 2008 Nov. : 3909-14
  • Tasian SK, Park JR, Martin ET, Englund JA
    Influenza-associated morbidity in children with cancer.
    Pediatric blood & cancer , 2008 May : 50(5)983-7
  • Tasian SK, Park JR, Martin ET, Englund JA
    Influenza-associated morbidity in children with cancer.
    Pediatric blood & cancer , 2008 May : 983-7
  • Zerr DM, Englund JA, Robertson AS, Marcuse EK, Garrison MM, Christakis DA
    Hospital-based influenza vaccination of children: an opportunity to prevent subsequent hospitalization.
    Pediatrics , 2008 Feb. : 345-8
  • Peck AJ, Englund JA, Kuypers J, Guthrie KA, Corey L, Morrow R, Hackman RC, Cent A, Boeckh M
    Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection.
    Blood , 2007 Sept. 1 : 1681-8
  • Heugel J, Martin ET, Kuypers J, Englund JA
    Coronavirus-associated pneumonia in previously healthy children.
    The Pediatric infectious disease journal , 2007 Aug. : 753-5
  • Vu D, Peck AJ, Nichols WG, Varley C, Englund JA, Corey L, Boeckh M
    Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America , 2007 July 15 : 187-93
  • Galanakis E, Englund JA, Abe P, Qin X
    Antimicrobial susceptibility of Bordetella pertussis isolates in the state of Washington.
    International journal of antimicrobial agents , 2007 May : 609-11
  • Kim YJ, Boeckh M, Englund JA
    Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection.
    Seminars in respiratory and critical care medicine , 2007 Apr, : 222-42
  • Qin X, Galanakis E, Martin ET, Englund JA
    Multitarget PCR for diagnosis of pertussis and its clinical implications.
    Journal of clinical microbiology , 2007 Feb. : 506-11
  • Boeckh M, Englund J, Li Y, Miller C, Cross A, Fernandez H, Kuypers J, Kim H, Gnann J, Whitley R, NIAID Collaborative Antiviral Study Group
    Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America , 2007 Jan. 15 : 44(2)245-9
  • Kuypers J, Martin ET, Heugel J, Wright N, Morrow R, Englund JA
    Clinical disease in children associated with newly described coronavirus subtypes.
    Pediatrics , 2007 Jan. : 119(1)e70-6
  • Kuypers J, Martin ET, Heugel J, Wright N, Morrow R, Englund JA
    Clinical disease in children associated with newly described coronavirus subtypes.
    Pediatrics , 2007 Jan. : e70-6
  • King JC Jr, Stoddard JJ, Gaglani MJ, Moore KA, Magder L, McClure E, Rubin JD, Englund JA, Neuzil K
    Effectiveness of school-based influenza vaccination.
    The New England journal of medicine , 2006 Dec. 14 : 2523-32
  • Neuzil KM, Englund JA
    Influenza vaccine for young children: two doses are better than one.
    The Journal of pediatrics , 2006 Dec. : 737-8
  • Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA
    Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Pediatrics , 2006 Sept. : e570-8
  • Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM
    Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Pediatrics , 2006 Sept. : e579-85
  • Englund JA, Boeckh M, Kuypers J, Nichols WG, Hackman RC, Morrow RA, Fredricks DN, Corey L
    Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients.
    Annals of internal medicine , 2006 Mar. 7 : 144(5)344-9
  • Englund JA, Boeckh M, Kuypers J, Nichols WG, Hackman RC, Morrow RA, Fredricks DN, Corey L
    Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients.
    Annals of internal medicine , 2006 Mar. 7 : 344-9
  • Gerber SI, Jones RC, Scott MV, Price JS, Dworkin MS, Filippell MB, Rearick T, Pur SL, McAuley JB, Lavin MA, Welbel SF, Garcia-Houchins S, Bova JL, Weber SG, Arnow PM, Englund JA, Gavin PJ, Fisher AG, Thomson RB, Vescio T, Chou T, Johnson DC, Fry MB, Molloy AH, Bardowski L, Noskin GA
    Management of outbreaks of methicillin-resistant Staphylococcus aureus infection in the neonatal intensive care unit: a consensus statement.
    Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America , 2006 Feb. : 139-45
  • Boeckh M, Erard V, Zerr D, Englund J
    Emerging viral infections after hematopoietic cell transplantation.
    Pediatric transplantation , 2005 Dec. : 9 Suppl 748-54
  • Van Rie A, Wendelboe AM, Englund JA
    Role of maternal pertussis antibodies in infants.
    The Pediatric infectious disease journal , 2005 May : 24(5 Suppl)S62-5
  • Wendelboe AM, Van Rie A, Salmaso S, Englund JA
    Duration of immunity against pertussis after natural infection or vaccination.
    The Pediatric infectious disease journal , 2005 May : S58-61
  • Van Rie A, Wendelboe AM, Englund JA
    Role of maternal pertussis antibodies in infants.
    The Pediatric infectious disease journal , 2005 May : S62-5
  • Tan T, Halperin S, Cherry JD, Edwards K, Englund JA, Glezen P, Greenberg D, Rothstein E, Skowronski D
    Pertussis immunization in the global pertussis initiative North American region: recommended strategies and implementation considerations.
    The Pediatric infectious disease journal , 2005 May : S83-6
  • Englund JA, Walter EB, Fairchok MP, Monto AS, Neuzil KM
    A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children.
    Pediatrics , 2005 Apr, : 115(4)1039-47
  • Englund JA, Walter EB, Fairchok MP, Monto AS, Neuzil KM
    A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children.
    Pediatrics , 2005 Apr, : 1039-47
  • Randolph AG, Reder L, Englund JA
    Risk of bacterial infection in previously healthy respiratory syncytial virus-infected young children admitted to the intensive care unit.
    The Pediatric infectious disease journal , 2004 Nov. : 23(11)990-4
  • Randolph AG, Reder L, Englund JA
    Risk of bacterial infection in previously healthy respiratory syncytial virus-infected young children admitted to the intensive care unit.
    The Pediatric infectious disease journal , 2004 Nov. : 990-4
  • Scott JD, Englund JA, Myerson D, Geballe AP
    Influenza A pneumonia presenting as progressive focal infiltrates in a stem cell transplant recipient.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology , 2004 Oct. : 96-9
  • DeVincenzo JP, Hall CB, Kimberlin DW, Sánchez PJ, Rodriguez WJ, Jantausch BA, Corey L, Kahn JS, Englund JA, Suzich JA, Palmer-Hill FJ, Branco L, Johnson S, Patel NK, Piazza FM
    Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis)-resistant mutants.
    The Journal of infectious diseases , 2004 Sept. 1 : 975-8
  • Imhof A, Balajee SA, Fredricks DN, Englund JA, Marr KA
    Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America , 2004 Sept. 1 : 743-6
  • Johnson LN, Han JY, Moskowitz SM, Burns JL, Qin X, Englund JA
    Pandoraea bacteremia in a cystic fibrosis patient with associated systemic illness.
    The Pediatric infectious disease journal , 2004 Sept. : 881-2
  • Tsuang WM, Bailar JC, Englund JA
    Influenza-like symptoms in the college dormitory environment: a survey taken during the 1999-2000 influenza season.
    Journal of environmental health , 2004 Apr, : 39-42, 44
  • Chantry CJ, Byrd RS, Englund JA, Baker CJ, McKinney RE Jr
    Growth, survival and viral load in symptomatic childhood human immunodeficiency virus infection.
    The Pediatric infectious disease journal , 2003 Dec. : 1033-9
  • Englund JA
    Maternal immunization with inactivated influenza vaccine: rationale and experience.
    Vaccine , 2003 July 28 : 21(24)3460-4
  • Englund JA, Glezen WP
    Maternal immunization with Haemophilus influenzae type b vaccines in different populations.
    Vaccine , 2003 July 28 : 3455-9
  • Englund JA
    Maternal immunization with inactivated influenza vaccine: rationale and experience.
    Vaccine , 2003 July 28 : 3460-4
  • Mongkolrattanothai K, Oram R, Redleaf M, Bova J, Englund JA
    Tuberculous otitis media with mastoiditis and central nervous system involvement.
    The Pediatric infectious disease journal , 2003 May : 453-6
  • Yu J, Briles DE, Englund JA, Hollingshead SK, Glezen WP, Nahm MH
    Immunogenic protein contaminants in pneumococcal vaccines.
    The Journal of infectious diseases , 2003 Mar. 15 : 1019-23
  • Capparelli EV, Englund JA, Connor JD, Spector SA, McKinney RE, Palumbo P, Baker CJ
    Population pharmacokinetics and pharmacodynamics of zidovudine in HIV-infected infants and children.
    Journal of clinical pharmacology , 2003 Feb. : 133-40
  • Cohen NJ, Oram R, Elsen C, Englund JA
    Response to changes in antiretroviral therapy after genotyping in human immunodeficiency virus-infected children.
    The Pediatric infectious disease journal , 2002 July : 647-53
  • Rennels MB, Deloria MA, Pichichero ME, Englund JA, Anderson EL, Steinhoff MC, Decker MD, Edwards KM
    Lack of consistent relationship between quantity of aluminum in diphtheria-tetanus-acellular pertussis vaccines and rates of extensive swelling reactions.
    Vaccine , 2002 May 31 : S44-7
  • Englund JA
    Antiviral therapy of influenza.
    Seminars in pediatric infectious diseases , 2002 Apr, : 120-8

Presentations

Presentations Title Event Location Date
Prevention Strategies for Pertussis: Maternal immunization and Cocooning World Society for Pediatric Infectious Diseases Cape Town, South Africa Nov. 19, 2013
Vaccines for special populations INDVAC (Indian Vaccinology Course) 2013 Vellore, India Sept. 18, 2013 - Sept. 21, 2013
New Respiratory Syncytial Virus Vaccines Maternal Immunization Conference Antalya, Turkey March 14, 2013
Respiratory virus infections in the immunocompromised host; Argentina Pediatric Infectious Disease Society Bueno Aires, Argentina March 13, 2013
Immunity to influenza following vaccination in children World Health Organization SAGE meeting Geneva Switzerland Feb. 14, 2012
Definition of ILI in Maternal Influenza Vaccine Studies Gates Foundation Maternal Immunization Study Meeting Kathmandu, Nepal May 25, 2011 - May 27, 2011
New Molecular Approaches for the Diagnosis of Viral Diseases State of the Art Plenary Session, PAS/SPR 2009 Baltimore, MD May 3, 0009

Research Funding

Grant Title Grantor Amount Award Date
Clinical Significance of rhinovirus Seattle Children's Hospital Clinical Translational Research Center Dec. 20, 2012 - Sept. 30, 2013
RSV surveillance and antibody levels in Southeast Asia PATH May 2012 - June 2014
New Vaccine Surveillance Network CDC Aug. 1, 2011 - July 31, 2015
Operation of a Facility for the Study of Infectious Agents, Vaccines, and Antimicrobials NIH/ Subsite of Johns Hopkins April 7, 2009 - April 6, 2013
Maternal Immunization to protect the Mother and Neonate Bill and Melinda Gates Fndn Jan. 2009 - Dec. 2014